SciELO - Scientific Electronic Library Online

 
vol.101 número6Identification of excreted iron superoxide dismutase for the diagnosis of PhtytomonasStudy of virulence factors in coagulase-negative staphylococci isolated from newborns índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Memórias do Instituto Oswaldo Cruz

versão impressa ISSN 0074-0276versão On-line ISSN 1678-8060

Resumo

SUCUPIRA, Michel VF et al. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem. Inst. Oswaldo Cruz [online]. 2006, vol.101, n.6, pp.655-660. ISSN 0074-0276.  http://dx.doi.org/10.1590/S0074-02762006000600013.

Hepatitis B virus (HBV) molecular profiles were determined for 44 patients who were infected with human immunodeficiency virus (HIV) type 1 and had antibodies to the hepatitis B core antigen (anti-HBc), with and without other HBV serological markers. In this population, 70% of the patients were under lamivudine treatment as a component of antiretroviral therapy. HBV DNA was detected in 14 (32%) patients. Eight out of 12 (67%) HBsAg positive samples, 3/10 (30%) anti-HBc only samples, and 3/22 (14%) anti-HBs positive samples were HBV DNA positive. HBV DNA loads, measured by real time polymerase chain reaction, were much higher in the HBsAg positive patients (mean, 2.5 ´ 109 copies/ml) than in the negative ones (HBV occult infection; mean, 2.7 ´ 105 copies/ml). Nine out of the 14 HBV DNA positive patients were under lamivudine treatment. Lamivudine resistant mutations in the polymerase gene were detected in only three patients, all of them belonging to the subgroup of five HBsAg positive, HBV DNA positive patients. A low mean HBV load (2.7 ´ 105 copies/ml) and an absence of lamivudine resistant mutations were observed among the cases of HBV occult infection.

Palavras-chave : hepatitis B virus; human immunodeficiency virus; lamivudine; drug resistance; mutations.

        · texto em Inglês     · Inglês ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons